Tag: Prescription Drugs
NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19
No clinical benefit found for hydroxychloroquine versus placebo in hospitalized adults with COVID-19
Antibody Treatment Approved for Emergency Use Against Early COVID-19
Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease
New Cancer Drug Approvals Linked to Drop in Mortality
New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.
Cabotegravir Injection Can Protect Women From HIV for Two Months
Experimental drug found to be 89 percent more effective at preventing HIV infection than Truvada pills
Panel Recommends Against Approval of Experimental Drug for Alzheimer Disease
FDA panel concluded there is not enough evidence to support the clinical effectiveness of aducanumab
Drug Combo Offers Long-Term Glycemic Control in T2DM
Reduction in HbA1c at 104 weeks greater with exenatide plus dapagliflozin versus either drug alone
Regulators Discuss Approval of New Alzheimer Disease Drug
Aducanumab does not cure or reverse Alzheimer disease; high dose may slow mental decline
Psilocybin Promising for Treating Major Depressive Disorder
Mean GRID Hamilton Depression Rating Scale scores significantly lower in immediate treatment group
Vosoritide Aids Bone Growth in Children With Dwarfism
